Dr. Kumar Sambhav, MD

Dr. Sambhav practices at Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia.

Dr. Sambhav's NPI, 1790216729, was assigned on March 22, 2017. Dr. Sambhav holds Oklahoma license 39138.

Dr. Sambhav's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD, at 33 Medical Center Dr, Morgantown, WV 26505.

Dr. Sambhav's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia. Dr. Sambhav is also affiliated with J.W. Ruby Memorial Hospital. The medical group on file is University Health Associates. Dmand AI also links Dr. Sambhav to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sambhav practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Sambhav's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Dr. Sambhav's licenses on file in 2 states: Oklahoma and Florida.

CMS data shows 220 Medicare services from Dr. Sambhav across 5 procedure codes in 2024, for 97 Medicare patients. Medicare paid $11,094 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 97 Medicare patients who saw Dr. Sambhav in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sambhav's median patient age at 66, with 46% women.

In 2024, Dr. Sambhav wrote 244 Medicare Part D claims for 97 patients. 63% of them were for generic drugs. CMS names the drug for 221 of them, across 8 drugs with 11 or more claims each, at $7,941 in total drug cost. In 2023, CMS named 85 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Sambhav for performance year 2024, reported through an alternative payment model (APM). Dr. Sambhav accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 22 general payments to Dr. Sambhav from 7 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 66% of the total. Alcon Laboratories Inc paid the most, $560.